CIRCADIAN VARIATION OF SUSTAINED VENTRICULAR-TACHYCARDIA IN PATIENTS WITH CORONARY-ARTERY DISEASE AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

被引:100
|
作者
LAMPERT, R [1 ]
ROSENFELD, L [1 ]
BATSFORD, W [1 ]
LEE, F [1 ]
MCPHERSON, C [1 ]
机构
[1] YALE UNIV,YALE NEW HAVEN HOSP,SCH MED,NEW HAVEN,CT 06504
关键词
CIRCADIAN RHYTHM; DEATH; SUDDEN; DEFIBRILLATION; TACHYCARDIA;
D O I
10.1161/01.CIR.90.1.241
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background While previous studies using epidemiological data and ambulatory ECG monitoring have shown peak occurrence of sudden death and nonsustained ventricular tachycardia in the morning, none have examined circadian variation of potentially life-threatening ventricular tachycardia (VT), nor has any study observed circadian behavior of any arrhythmias in individuals followed longitudinally. We used the event memory of multiprogrammable implantable cardioverter-defibrillators to evaluate the circadian pattern of sustained VT over time. Methods and Results Data were reviewed from 32 consecutive patients with coronary artery disease and sustained VT who had received the Ventak PRX (CPI, Inc) cardioverter-defibrillator between May 1991 and August 1993 and had experienced at least one episode of VT terminated by their device. Mean follow-up was 14+/-7 months. Among the 2558 episodes recorded by the device logs, VT occurrence peaked between 6 AM and noon (P=.007 by ANOVA among four 6-hour time periods). Harmonic regression revealed a morning peak at 9 AM (P<.01). This morning peak occurred in patients with both frequent and infrequent events. Among 21 patients who experienced more than four VT events, 8 (38%) had an AM peak of VT occurrence (>35% of VT between 6 AM and noon). Neither age, ejection fraction, event frequency, presenting arrhythmia, nor drug therapy distinguished patients who displayed the AM VT peak. Conclusions In patients with coronary artery disease, sustained VT displays circadian variation with peak frequency in the morning, similar to that for sudden death. Individual patients who display specific patterns of circadian variation over time can be identified using defibrillator logs. Investigation of circadian variation of other phenomena to elucidate mechanisms of VT should focus on these patients.
引用
收藏
页码:241 / 247
页数:7
相关论文
共 42 条
  • [31] Reversible Cause of Cardiac Arrest and Secondary Prevention Implantable Cardioverter Defibrillators in Patients With Coronary Artery Disease: Value of Complete Revascularization and LGE-CMR
    Van der Lingen, Anne-Lotte C. J.
    Becker, Marthe A. J.
    Kemme, Michiel J. B.
    Rijnierse, Mischa T.
    Spoormans, Eva M.
    Timmer, Stefan A. J.
    van Rossum, Albert C.
    van Halm, Vokko P.
    Germans, Tjeerd
    Allaart, Cornelis P.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (08):
  • [32] Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease
    Wathen, MS
    Sweeney, MO
    DeGroot, PJ
    Stark, AJ
    Koehler, JL
    Chisner, MB
    Machado, C
    Adkisson, WO
    CIRCULATION, 2001, 104 (07) : 796 - 801
  • [33] Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease - An analysis of patients enrolled in the Multicenter Unsustained Tachycardia Trial
    Buxton, AE
    Lee, KL
    Hafley, GE
    Wyse, DG
    Fisher, JD
    Lehmann, MH
    Pires, LA
    Gold, MR
    Packer, DL
    Josephson, ME
    Prystowsky, EN
    Talajic, MR
    CIRCULATION, 2002, 106 (19) : 2466 - 2472
  • [34] General and Disease-Specific Psychosocial Adjustment in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy With Implantable Cardioverter Defibrillators: A Large Cohort Study
    James, Cynthia A.
    Tichnell, Crystal
    Murray, Brittney
    Daly, Amy
    Sears, Samuel F.
    Calkins, Hugh
    CIRCULATION-CARDIOVASCULAR GENETICS, 2012, 5 (01) : 18 - 24
  • [35] CHA2DS2-VASC score predicts coronary artery disease progression and mortality after ventricular arrhythmia in patients with implantable cardioverter-defibrillator
    Kavsur, Refik
    Becher, Marc Ulrich
    Nassan, Welat
    Sedaghat, Alexander
    Aksoy, Adem
    Schrickel, Jan Wilko
    Nickenig, Georg
    Tiyerili, Vedat
    IJC HEART & VASCULATURE, 2021, 34
  • [36] Entrainment/mapping criteria for the prediction of termination of ventricular tachycardia by single radiofrequency lesion in patients with coronary artery disease
    El-Shalakany, A
    Hadjis, T
    Papageorgiou, P
    Monahan, K
    Epstein, L
    Josephson, ME
    CIRCULATION, 1999, 99 (17) : 2283 - 2289
  • [37] Revascularization of coronary chronic total occlusions in an infarct-related artery and recurrence of ventricular arrhythmias among patients with secondary prevention implantable cardioverter defibrillator
    Di Marco, Andrea
    Anguera, Ignasi
    Nombela-Franco, Luis
    Oloriz, Teresa
    Teruel, Luis
    Rodriguez Manero, Moises
    Toquero, Jorge
    Leon, Valentina
    Dallaglio, Paolo
    Perez Guerrero, Ainhoa
    Salazar, Carlos Hernando
    Escaned, Javier
    Asso Abadia, Antonio
    Gomez Hospital, Joan Antoni
    Cequier, Angel
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 (01) : E1 - E11
  • [38] Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy During Long-Term Follow-up of Patients With Coronary Artery Disease
    Blumer, Johannes
    Wolber, Thomas
    Hellermann, Jens
    Holzmeister, Johannes
    Binggeli, Christian
    Duru, Firat
    Brunckhorst, Corinna
    INTERNATIONAL HEART JOURNAL, 2009, 50 (03) : 313 - 321
  • [39] Meta-Analysis of Risk of Ventricular Arrhythmias and All-Cause Mortality in Patients With Chronic Total Occlusion of a Coronary Artery and/or Implantable Cardioverter-Defibrillator
    Wang, Zhi-Quan
    Qiang, Hua
    Luo, Xiu
    Li, Wei
    Guo, Kai
    Li, Yi-Gang
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (10) : 1149 - 1154
  • [40] Comparison of effective and ineffective target sites that demonstrate concealed entrainment in patients with coronary artery disease undergoing radiofrequency ablation of ventricular tachycardia
    Bogun, F
    Bahu, M
    Knight, BP
    Weiss, R
    Paladino, W
    Harvey, M
    Goyal, R
    Daoud, E
    Man, KC
    Strickberger, SA
    Morady, F
    CIRCULATION, 1997, 95 (01) : 183 - 190